DE3484909D1 - Verfahren zur herstellung von biologisch aktiven stoffen. - Google Patents

Verfahren zur herstellung von biologisch aktiven stoffen.

Info

Publication number
DE3484909D1
DE3484909D1 DE8484102688T DE3484909T DE3484909D1 DE 3484909 D1 DE3484909 D1 DE 3484909D1 DE 8484102688 T DE8484102688 T DE 8484102688T DE 3484909 T DE3484909 T DE 3484909T DE 3484909 D1 DE3484909 D1 DE 3484909D1
Authority
DE
Germany
Prior art keywords
biologically active
active substances
producing biologically
producing
substances
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8484102688T
Other languages
English (en)
Inventor
Tadayoshi Taniyama
Koichi Asahi Kasei Nis Yoshida
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Asahi Kasei Corp
Asahi Chemical Industry Co Ltd
Original Assignee
Asahi Chemical Industry Co Ltd
Asahi Kasei Kogyo KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asahi Chemical Industry Co Ltd, Asahi Kasei Kogyo KK filed Critical Asahi Chemical Industry Co Ltd
Application granted granted Critical
Publication of DE3484909D1 publication Critical patent/DE3484909D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/525—Tumour necrosis factor [TNF]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/545—IL-1
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C12N5/12—Fused cells, e.g. hybridomas
    • C12N5/16—Animal cells
    • C12N5/163—Animal cells one of the fusion partners being a B or a T lymphocyte

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Wood Science & Technology (AREA)
  • Toxicology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE8484102688T 1983-03-15 1984-03-12 Verfahren zur herstellung von biologisch aktiven stoffen. Expired - Lifetime DE3484909D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP58041409A JPS59169492A (ja) 1983-03-15 1983-03-15 ヒト融合細胞からの生理活性物質の産生方法

Publications (1)

Publication Number Publication Date
DE3484909D1 true DE3484909D1 (de) 1991-09-19

Family

ID=12607555

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8484102688T Expired - Lifetime DE3484909D1 (de) 1983-03-15 1984-03-12 Verfahren zur herstellung von biologisch aktiven stoffen.

Country Status (5)

Country Link
US (1) US4711842A (de)
EP (1) EP0118917B1 (de)
JP (1) JPS59169492A (de)
DE (1) DE3484909D1 (de)
HU (1) HU191397B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4879226A (en) * 1984-04-06 1989-11-07 Asahi Kasei Kogyo Kabushiki Kaisha Novel human physiologically active polypeptide
NL8401221A (nl) * 1984-04-16 1985-11-18 Innovi Nv Analytische toepassing van fagocyt-cellijnen.
DE3683186D1 (de) 1985-04-25 1992-02-13 Hoffmann La Roche Rekombinantes humaninterleukin-1.
DE3520844A1 (de) * 1985-06-11 1986-12-11 Behringwerke Ag, 3550 Marburg Thymidin-kinase (ec 2.7.1.21)-mangelmutanten einer humanen monocytischen zellinie
ZA874410B (en) * 1986-06-24 1988-04-27 Merrell Dow Pharma Fusion products
US4801686A (en) * 1986-09-04 1989-01-31 Immunex Corporation Purification of recombinant interleukin-1
US20010012632A1 (en) * 1995-03-31 2001-08-09 Muriel Moser Dendritic-like cell/tumor cell hybrids and hybridomas for inducing an anti-tumor response
US5695760A (en) * 1995-04-24 1997-12-09 Boehringer Inglehiem Pharmaceuticals, Inc. Modified anti-ICAM-1 antibodies and their use in the treatment of inflammation

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57502090A (de) * 1980-07-18 1982-11-25
US4438032A (en) * 1981-01-30 1984-03-20 The Regents Of The University Of California Unique T-lymphocyte line and products derived therefrom
US4544632A (en) * 1981-06-12 1985-10-01 Yuichi Yamamura Human T cell lines and method of producing same
JPS6011889B2 (ja) * 1981-10-28 1985-03-28 電気化学工業株式会社 継代可能なリンホカイン産生ヒトｔ細胞融合株及びその取得方法
US4529694A (en) * 1982-04-16 1985-07-16 The Children's Medical Center Corporation Cell fusion

Also Published As

Publication number Publication date
US4711842A (en) 1987-12-08
EP0118917A2 (de) 1984-09-19
EP0118917B1 (de) 1991-08-14
EP0118917A3 (en) 1987-08-19
JPS59169492A (ja) 1984-09-25
HU191397B (en) 1987-02-27

Similar Documents

Publication Publication Date Title
DE3486147D1 (de) Verfahren zur herstellung von l-isoleucin.
DE3587442D1 (de) Verfahren zur herstellung von polysilsesquioxanen.
DE3586263D1 (de) Verfahren zur herstellung von abbildungen.
DE3669310D1 (de) Verfahren zur herstellung von cycloolefinen.
DE3575423D1 (de) Verfahren zur herstellung von heteroaryloxyacetamiden.
DE3762745D1 (de) Verfahren zur herstellung von 2-chlor-5-chlormethylthiazol.
DE3586638D1 (de) Verfahren zur herstellung von vanadylphthalocyanin.
DE3578062D1 (de) Verfahren zur herstellung von iodbenzol.
DE3763558D1 (de) Verfahren zur herstellung von 2-chlor-5-chlormethylpyridin.
DE3773889D1 (de) Verfahren zur herstellung von merkaptomethylphenolen.
DE3668316D1 (de) Verfahren zur herstellung von cycloolefinen.
DE3780704D1 (de) Verfahren zur herstellung von n-acyltetrahydroisochinoline.
DE3483599D1 (de) Verfahren zur herstellung von riboflavin.
DE3585219D1 (de) Verfahren zur herstellung von n-formyl-alpha-aspartyl-phenylalaninen.
DE3575133D1 (de) Verfahren zur herstellung von 1-alkyl- oder 1-cycloalkylpiperazinen.
DE3579858D1 (de) Verfahren zur herstellung von p-isobutylstyrol.
DE3584754D1 (de) Verfahren zur herstellung von arylalkylketonen.
DE3484909D1 (de) Verfahren zur herstellung von biologisch aktiven stoffen.
DE3766910D1 (de) Verfahren zur herstellung von dihydrocyclocitral.
DE3769076D1 (de) Verfahren zur herstellung von fluorbenzaldehyden.
DE3670075D1 (de) Verfahren zur herstellung von bis-hydroxyphenyl-n-alkanen.
DE3581667D1 (de) Verfahren zur herstellung von 5-deoxy-l-arabinose.
DE3777475D1 (de) Verfahren zur herstellung von polyphenylen-ether-polyester-copolymeren.
DE3769263D1 (de) Verfahren zur herstellung von bromfluoroethylhypofluorit.
DE3576816D1 (de) Verfahren zur herstellung von chlor-o-nitroanilinen.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee